Page last updated: 2024-10-31

modafinil and Cardiovascular Stroke

modafinil has been researched along with Cardiovascular Stroke in 1 studies

Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.

Research Excerpts

ExcerptRelevanceReference
"Modafinil users were matched with nonusers."1.48Modafinil and the risk of cardiovascular events: Findings from three US claims databases. ( Goehring, EL; Jones, JK; Kaplan, S; Knebel, H; Melamed-Gal, S; Nguyen-Khoa, BA, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaplan, S1
Goehring, EL1
Melamed-Gal, S1
Nguyen-Khoa, BA1
Knebel, H1
Jones, JK1

Other Studies

1 other study available for modafinil and Cardiovascular Stroke

ArticleYear
Modafinil and the risk of cardiovascular events: Findings from three US claims databases.
    Pharmacoepidemiology and drug safety, 2018, Volume: 27, Issue:11

    Topics: Administrative Claims, Healthcare; Adolescent; Adult; Aged; Cause of Death; Confounding Factors, Epi

2018